START Cancer Research New York-Long Island — Lake Success, New York

START Cancer Research New York-Long Island is a clinical research site located in Lake Success, New York, United States 11042.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

START Cancer Research New York-Long Island has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer.

Sponsors: Aminex Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lake Success

Browse all research sites in New York · View every site in Lake Success

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START Cancer Research New York-Long Island?

START Cancer Research New York-Long Island has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START Cancer Research New York-Long Island conducted?

START Cancer Research New York-Long Island has 1 clinical trials on record, with 1 currently active. Their work covers Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer.

Is START Cancer Research New York-Long Island accredited by Crixeo Clinical Trials?

START Cancer Research New York-Long Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START Cancer Research New York-Long Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.